C-reactive protein 1059G/C gene polymorphism, C-reactive protein levels and acute myocardial infarction

J Cardiovasc Med (Hagerstown). 2012 Nov;13(11):716-9. doi: 10.2459/JCM.0b013e3283577170.

Abstract

Aims: High-sensitivity C-reactive protein (hs-CRP) is an inflammatory marker, predicting the occurrence of acute myocardial infarction (AMI). Genetic predisposition to high baseline CRP might account for a high risk of heart diseases. Our study aimed at investigating an association of CRP 1059G/C gene polymorphism with plasma CRP levels and AMI in Egyptian patients.

Methods: Genotypes of 150 patients with AMI and 150 healthy sex and age-matched controls were analyzed using PCR-restriction fragment length polymorphism methods. hs-CRP concentrations were assessed.

Results: There was no significant association between CRP 1095G/C polymorphism and AMI. However, individuals with GG genotype had significantly higher plasma CRP concentration than those with GC and CC genotypes, in both controls (3.82 ± 1.03 vs. 2.34 ± 0.7; P = 0.001) and patients with AMI (8.39 ± 2.6 vs. 6.67 ± 2.4; P = 0.005).

Conclusion: Our results revealed that CRP 1059G/C gene variation influences plasma CRP levels. Conversely, this polymorphism was not associated with the risk for AMI.

MeSH terms

  • Adult
  • Amplified Fragment Length Polymorphism Analysis
  • Biomarkers / blood
  • C-Reactive Protein / analysis*
  • C-Reactive Protein / genetics*
  • Case-Control Studies
  • Chi-Square Distribution
  • Egypt
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Inflammation Mediators / blood*
  • Linear Models
  • Male
  • Middle Aged
  • Myocardial Infarction / blood*
  • Myocardial Infarction / genetics*
  • Phenotype
  • Polymorphism, Genetic*
  • Risk Factors
  • Up-Regulation

Substances

  • Biomarkers
  • Inflammation Mediators
  • C-Reactive Protein